Progesterone (Compound)

Synonyms:progesterone, 57-83-0, Pregn-4-ene-3,20-dione, Agolutin, Luteohormone, Crinone, 4-Pregnene-3,20-dione, Corpus luteum hormone, Progestin, Syngesterone, Utrogestan, Luteol, Glanducorpin, Pregnenedione, Progesterol, Corlutin, Cyclogest, Gesterol, Gestone, Gestormone, Progestone, Progestron, Prometrium, Hormoflaveine, Methylpregnone, Progestasert, Progesteronum, Progestronol, Corlutina, Corluvite, Corporin, Flavolutan, Fologenon, Gynlutin, Gynolutone, Hormoluton, Lingusorbs, Lucorteum, Luteodyn, Luteogan, Luteopur, Luteosan, Luteostab, Luteovis, Lutociclina, Lutocyclin, Lutocylin, Lutoform, Lutromone, Membrettes, Nalutron, Piaponon, Primolut, Progekan, Progestosol, Prolidon, Proluton, Protormone, Syngestrets, Syntolutan, Gestron, Lutidon, Lutogyl, Lutren, Prolets, Lutex, Luteal hormone, Lucorteum Sol, Bio-luton, Lutocyclin M, Lipo-Lutin, Luteocrin normale, Luteinique, Prochieve, Prolutone, Lutin, 17alpha-Progesterone, Synovex S, Projestaject, Gynoluton, Gesterol 50, Percutacrine Luteinique, Gesterol 100, Cyclogesterin, Akrolutin, Prolutin, Pregnene-3,20-dione, (S)-Progesterone, Colprosterone, Endometrin, Progesteron, Progestogel, Progeston, 3,20-Pregnene-4, Gelbkoerperhormon, Crinone progesterone gel, Gestiron, Lugesteron, Progestol, Luteol (VAN)
Pubchem:PUBCHEM:5994
Id:5994
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Progesterone's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Progesterone.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Progesterone.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.